CorMedix (CRMD) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 50%. A quarter ago, it was expected that this pharmaceutical and medical device company would post a loss of $0.26 per share when it actually produced a loss of $0.25, delivering a surprise of 3.85%. Over the last four quarters, ...